Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Northwest Biotherapeutics (NWBO) has issued an update.
After over ten years of dedicated service, Mr. Jerry Jasinowski has retired from the Board of Directors at Northwest Biotherapeutics, Inc. as of March 8, 2024. At 85 years old, his retirement is attributed to health reasons and bears no connection to any disputes over the company’s operations, policies, or practices. Northwest Biotherapeutics extends its gratitude to Mr. Jasinowski for his longstanding commitment to the Board.
See more insights into NWBO stock on TipRanks’ Stock Analysis page.

